Newsroom

News May 22, 2024

Coverage and new Special Authorization requirements for Chronic Weight Management products

Wegovy, a prescription drug that contains the same active ingredient as Ozempic (semaglutide), recently became available in Canada, prompting inquiries regarding coverage. While these drugs have the same active ingredient, Ozempic has been approved by Health Canada for treatment of Type II diabet...

Read More

June 12th, 2019

Saskatchewan Blue Cross Proudly Supports Saskatoon Heart Safe

Read More

March 1st, 2019

Record Number of Communities Register for Go Out & Play Challenge

Read More

March 1st, 2019

Saskatchewan Blue Cross Proud to Support Travel Wishes

Read More

February 13th, 2019

Saskatchewan’s Top Employers

Read More

June 13th, 2018

PST Refund Cheques Issued to Individual & Travel Insurance Policy Holders

Read More

April 12th, 2018

Update: PST Refunds on Insurance Premiums

Read More